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Abstract: Objectives: Previous studies have shown that dietary components such as oleic acid or 18 
polyphenols exert beneficial effects on endothelium. We aimed to assess the impact of regular 19 
consumption of Iberian cured-ham (ICH) on endothelial function. Design: An open-label, 20 
randomized controlled parallel study. Setting: Volunteers recruited through advertisements at a 21 
hospital in Madrid, Spain. Participants: 102 Caucasian adults (76.8% females) aged 25–55 years, 22 
and free from cardiometabolic disease. Intervention: Participants were randomized to an ICH-23 
enriched ad libitum diet or an ad libitum diet without ICH for 6 weeks. Subjects in ICH group were 24 
randomly provided with either acorn- or mixed-fed ICH, and followed up for an additional 6-week 25 
period under their usual diet. Measurements: Clinical parameters, biomarkers of endothelial function 26 
and oxidative stress, microvascular vasodilatory response to hyperemia and arterial stiffness were 27 
measured before and after the intervention. Results: After 6 weeks, a larger decrease in PAI-1 was 28 
observed in subjects consuming ICH compared to the Control group (-6.2±17.7 vs. 0.3±1.4 ng/ml; 29 
p=0.020). Similarly, microvascular vasodilatory response to hyperemia showed a significant increase 30 
(112.4±391.7 vs. -56.0±327.9%; p=0.007). However, neither oxidative stress, hemodynamic nor 31 
clinical parameters differed significantly over the study. Additionally, after stopping ICH 32 
consumption, improvements in PAI-1 remained for 6 additional weeks with respect to baseline 33 
(p=0.006). Conclusion: The present study demonstrates, for the first time, that regular consumption 34 
of ICH improves endothelial function in healthy adults. Strategies aimed to preserve or improve the 35 
endothelial function may have implications in vascular aging beyond the prevention of the 36 
atherothrombotic disease.  37 
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INTRODUCTION 39 
The endothelium is a metabolically active organ playing a  critical role in the regulation of vascular 40 
wall homeostasis (1). Loss of balance between endothelial-derived vasodilatory and vasoconstrictory 41 
factors is associated with progressive changes (2) including pro-inflammatory, pro-oxidant, 42 
proliferative and prothrombotic status, as well as an abnormal modulation of vascular tone, all of 43 
which characterize the endothelial dysfunction (ED) (3). ED is recognized as a critical, early, 44 
modifiable step in the development and progression of atherosclerosis (4).  45 
A large number of studies (5-8) have investigated the role of diet and dietary components on the 46 
endothelial function. These include the Mediterranean diet (MD), a traditional food pattern which has 47 
been associated with a lower incidence of cardiovascular disease (9). Constituents of MD such as 48 
virgin olive oil and nuts, both high in unsaturated fatty acids and phenolic compounds, have been 49 
demonstrated to favorably impact on oxidative stress and endothelial function (10-12).  50 
Dry-cured ham is a traditional product based on preservation of pork food through salting and curing, 51 
with a strong presence in countries in the Mediterranean area since ancient time. 52 
Iberian cured-ham (ICH) is produced from Iberian pigs, a free-range reared genotype native to South-53 
western Spain and South-eastern Portugal. Nutritional characteristics of ICH depend mainly on pig 54 
feed, which can be based only on acorn and pasture (“acorn-fed”) or also including compound feeds 55 
(“mixed-fed”). ICH is particularly rich in unsaturated fatty acids, especially in oleic acid (from 50% 56 
to 55% of its fat content in mixed- and acorn-fed types respectively), and polyphenols (mainly gallic 57 
and ellagic acid derivatives and quercetin) (13). Only a few studies have attempted to assess the 58 
effects of regular consumption of dry-cured ham on atherogenic risk factors, reporting beneficial 59 
actions on lipid panel (14) and lipid peroxidation (15). More recently, consumption of dry-cured ham 60 
was not associated with a higher risk of cardiovascular disease, hypertension or weight gain (16).  61 
The current study is therefore the first to assess the effects of regular consumption of ICH on 62 
endothelial function. Within the context of a regular dietary pattern in healthy adults, it would provide 63 
value in understanding how ICH affects early cardiovascular risk markers.  64 
The primary aim of the current study was to assess whether regular consumption of ICH improves 65 
PAI-1, a circulating marker of endothelial function, compared with a control group following their 66 
usual diet. Secondary objectives were to identify its effects on microvascular endothelial function, 67 
oxidative stress biomarkers and arterial stiffness. We also aimed to describe whether there was a 68 
lasting effect on endothelium after stopping the consumption of ICH.  69 
Materials and methods  70 
Experimental design  71 
This study was an open-label, randomized controlled parallel study conducted at a cardiovascular risk 72 
unit of a university hospital in Madrid, Spain.  73 
Participants were asked to stop the consumption of ICH, as well as to maintain their previous intake 74 
of foods high in oleic acid or polyphenols, such as crude virgin olive oil, green tea or red berries from 75 
one week before baseline, and thereafter for the duration of the study. At baseline, participants were 76 
randomized to either ICH group, consisting of an ICH-enriched ad libitum diet for 6 weeks, or Control 77 
group, following an ad libitum diet without ICH. For subjects in ICH group, one of two possible types 78 
of ICH, acorn-fed or mixed-fed, were randomly assigned and provided as daily servings (50g). They 79 
were also counseled by a nutritionist about strategies for equivalently substituting calories from ICH 80 
in their regular diet. All participants were advised to follow their otherwise usual dietary and physical 81 
activity patterns throughout the study. Within 3 weeks after the randomization, participants were 82 
contacted to ensure compliance with the study protocol. After the 6-week intervention period, 83 
subjects in ICH group were followed up for an additional 6-week period under their usual diet, 84 
without ICH. Study measurements were made at baseline and after 6 weeks for all participants, and 85 
after 12 weeks only for ICH group.  86 
Subjects  87 
A total of 142 healthy volunteers, free from cardiometabolic disease, were recruited through 88 
advertisements at Ramon y Cajal University Hospital in Madrid, Spain. Participants were required to 89 
be Caucasian adults aged 25–55 years with a body mass index (BMI) between 18.5 and 30 kg/m2, 90 
willing to daily consume ICH and to comply with study protocol, and able to provide written informed 91 
consent. Participants were excluded if they had been diagnosed with atherosclerotic vascular disease, 92 
diabetes, hypertension, dyslipidemia, metabolic syndrome (17), hyperferritinemia, or having at least 93 
one of the following risk factors: HDL-cholesterol ≤35 mg/dL, LDL-cholesterol ≥130 mg/dL, 94 
triglycerides ≥150 mg/dL, hemoglobin A1c ≥5,7%, fasting plasma glucose ≥100 mg/dL. Moderate 95 
to heavy smokers (>10 cigarettes/day) were also excluded. Additionally, any other condition that 96 
could interfere with study participation, such as pregnancy, alcohol or drug abuse, mental disorders, 97 
anemia, kidney, pulmonary or liver disease, was excluded. Of the 142 respondents, 38 failed to 98 
complain with incursion/exclusion criteria: 29 lipid profile, 8 BMI, 1 age. Two participants withdrew 99 
before randomization, leaving 102 to be randomized.  100 
Clinical measurements  101 
Height and body weight were measured while wearing light clothing and no shoes, and BMI (kg/m2) 102 
was calculated. Waist circumference was measured in the standing position, midway between the 103 
lowest rib and iliac crest, directly on the skin. Body fat mass percentage was measured using the 104 
bioelectrical impedance method (Omron BF300). Systolic (SBP) and diastolic (DBP) blood pressure 105 
were measured in the sitting position after 5 min of rest, using an automated sphygmomanometer 106 
(Omron 705CP), the mean of three measurements was used. Medical history, 1st-degree family 107 
history of cardiovascular disease (parents or siblings <55 years in men and <65 in women), physical 108 
inactivity (<90 min/week of walking), smoking status and food frequency (18), were recorded at 109 
baseline.  110 
Laboratory measurements  111 
Overnight fasting blood samples and first-void urine samples were collected and processed. 112 
Concentrations of total cholesterol, triglycerides, HDL-C, LDL-C, blood glucose, uric acid and urine 113 
creatinine were analyzed in the certified local laboratory using standard procedures. Aliquots for 114 
biomarker assessment were stored at -80ºC until all participants completed the study. Biomarkers 115 
were measured using commercial cytokine enzyme-linked immunosorbent assays: Plasminogen 116 
activator inhibitor-1 (PAI-1) (ng/ml), Meranini; Thiobarbituric acid reactive substances (TBARS) 117 
(μM/L), Cayman; F2-isoprostanes (ng/ml), Northwest.  118 
Microvascular endothelial function  119 
Laser-Doppler flowmeter DRT4 (Moor Instruments, UK) was used to measure ischemic reactive 120 
hyperemia. With the subject lying in the supine position in a room with stable temperature (20-22°C), 121 
the laser probe was placed close to the wrist, distal from a blood pressure cuff placed above the elbow. 122 
Skin temperature was controlled using a probe heated to a thermoneutral temperature (33ºC). After a 123 
5-min resting period, basal capillary flow (arbitrary perfusion units) was measured for 3 min. 124 
Thereafter, 3-min distal ischemia was induced by inflating the cuff to suprasystolic pressure. 125 
Subsequently, the cuff was deflated and the flow during reactive hyperemia was recorded for 3 min. 126 
Ischemic reactive hyperemia index (IRHi) was calculated as: 100 x (peak hyperemic flow – baseline 127 
flow) / (baseline flow), and expressed as a percentage.  128 
Central pressure and arterial stiffness  129 
Central blood pressure parameters were measured by applanation tonometry using the SphygmoCor 130 
system (AtCor Medical, Australia) over the radial artery, with the subject in the sitting position. The 131 
augmentation index (AIx@75), an indirect measure of arterial stiffness, was calculated as 132 
augmentation pressure divided by pulse pressure ×100 to give a percentage, and normalized to heart 133 
rate at 75 bpm (19). 134 
Sample size The main outcome variable was the difference between baseline and after 6 weeks for 135 
PAI-1 (ng/ml). Based on previous data, a sample size of 52 subjects in each group was needed to 136 
have 80% power to detect a difference in PAI-1 levels of 5 units (SD: 9 units), using the Student’s t-137 
test for independent samples, considering a statistical significance value of 0.05. Analysis of total 138 
phenolic content 6 samples (2.5g) of each of both acorn- and mixed-fed ICH were assessed for total 139 
phenolic content, according to Folin- Ciocalteu method (20). Gallic acid was used as a standard and 140 
ellagic acid as a reference, since ellagitannins are located deeper in ICH. Ethics Protocol and consent 141 
form were approved by the Ramon y Cajal Hospital Clinical Research Ethics Committee (Madrid, 142 
Spain). Signed informed consent was obtained from all study participants before study enrolment. 143 
Those who completed the study received non-monetary compensation for their participation (a batch 144 
of ICH). Statistical analyses Statistical analyses were performed using SPSS 15 for Windows (SPSS, 145 
Inc., Chicago, IL, USA). Values were expressed as percentages or as mean ± standard deviation (SD). 146 
Prior to hypothesis testing, data were examined for normality. Differences at baseline between groups 147 
were assessed by student t-test for independent samples. Changes within ICH after 12 weeks were 148 
tested according to t-test for paired samples. Primary and secondary outcomes at 6-weeks were tested 149 
using univariate analysis of variance, adjusting for baseline values. The alpha level of significance 150 
was p<0.05. Results Baseline characteristics A total of 102 participants started the study; however 151 
two participants withdrew from the ICH group (n=1 withdrew consent; n=1 became pregnant during 152 
the trial), leaving 100 participants to complete the study. One was excluded from data analysis due 153 
to incomplete biological samples. Finally the analyzed study population included 99 subjects (48 in 154 
the ICH group and 51 controls). Subjects from the ICH group were also randomized to consume 155 
either acorn-fed (n=26) or mixed-fed (n=22) ICH. The mean age was 40.2 ± 8.7 years, with a 156 
predominance of females (76.8%). Sedentary subjects constitute 13.1% of the study population, and 157 
33.3% had 1st-degree family history of cardiovascular disease. 21.2% were current light smokers and 158 
6.1% ex-smokers (>1 year). At baseline, there were no statistically significant differences between 159 
the control and the intervention (ICH) group in age (40.5 ± 8.9 versus 39.9 ± 8.5 years), gender 160 
distribution (82.4% vs. 70.8% females) or clinical characteristics (Table 1). In addition, the mean age 161 
of the women was also similar in both groups. Changes after 6 weeks When assessing the mean 162 
adjusted change in PAI-1 over 6 weeks, there was a diet effect (p=0.020). Those in the ICH group 163 
had a larger decrease in PAI-1 (-6.2 ± 17.7 ng/ml) compared to controls (0.3 ± 1.4 ng/ml) (Table 2). 164 
Similarly, subjects in the ICH group showed a significant increase (p=0.007) in the ischemic reactive 165 
hyperemia index (IRHi) (112.4 ± 391.7%), when compared to the Control group (-56.0 ± 327.9%). 166 
Otherwise, neither oxidative biomarkers nor central hemodynamic parameters differed significantly 167 
between both groups over the study. Similarly, none of the clinical variables reported in Table 1 168 
showed significant differences between subjects in both groups over 6 weeks. 169 
Secondary analyses: type of ICH and follow-up period With regard to the type of ICH, different 170 
behaviors were observed in the main endothelial outcomes between subjects eating acorn- and mixed-171 
fed ICH (Figure 1). Similar trends were seen in PAI-1 after 6 weeks for both ICH (-7.7 ± 19.2 vs. -172 
4.4 ± 16.1 ng/ml) despite of different baseline values, while only subjects who consumed acorn-fed 173 
ICH exhibited an improving trend according to IRHi (259.5 ± 358.6 vs. -43.8 ± 373.6%). After the 174 
end of regular consumption of ICH, PAI-1 values remained significantly lower for 6 additional weeks 175 
with respect to baseline (15.8 ± 12.1 ng/ml at week 12, p=0.006). IRHi also showed an improving 176 
trend (522.3 ± 317.8% at w12), though this did not reach statistical significance (Figure 1). 177 
Total phenolic content in ICH The analysis for total phenolic content in ICH showed that the acorn-178 
fed samples were higher in polyphenols than the mixed-fed (1.43 ± 0.09 vs. 1.06 ± 0.20 μg/g ICH). 179 
Discussion To the best of our knowledge, this is the first study to demonstrate that regular 180 
consumption of Iberian cured-ham improves endothelial function in healthy adults. One of the most 181 
important observations in this study involves a significant decrease in PAI-1 levels, the primary 182 
endpoint, after regular consumption of ICH. Plasminogen activator inhibitor-1 is an anti-fibrinolytic 183 
(21) peptide which, under physiological conditions, is produced by hepatocytes, adipose tissue and 184 
endothelium. In response to a variety of noxious stimuli, endothelial synthesis of PAI-1 increases 185 
markedly, leading to a hypofibrinolytic and prothrombotic state which characterizes the endothelial 186 
dysfunction (3). Beneficial effects of ICH on endothelial function, and particularly on PAI-1 levels, 187 
could be related to its high content in monounsaturated fatty acids (MUFA), mainly oleic acid (13). 188 
Previous studies using MUFA support findings of a fall in PAI-1 (22, 23). Moreover, Mediterranean 189 
diet (MD), an acid oleic-rich diet, has been also demonstrated to lower basal levels of PAI-1 (24). 190 
Interestingly, most of the fat content of genuine Mediterranean diet (MD) is derived from virgin olive 191 
oil, which, like ICH, also contains a range of non-fat micronutrients with a high biological potency, 192 
including phenols (12). Presence of phenolic compounds in virgin olive oil has been associated with 193 
antithrombotic properties (24) and improvements in endothelial function (10).  194 
With regard to microvascular vasodilatory response to post-ischemic hyperemia, our results are in 195 
line with the currently available evidence supporting beneficial effects of regular consumption of 196 
several dietary compounds, as unsaturated fatty acids and polyphenols, on endothelium-dependent 197 
vasodilation (5-8). It should be noted however that almost all of these studies are based on a 198 
macrovascular measurement of endothelial function, flow-mediated dilatation (FMD) (25). Because 199 
of the different physiological role of conduit arteries and small vessels, important differences should 200 
be considered between micro- and macrovascular endothelial function, as both only show a weak 201 
correlation with each other (26). Even so, Ruano et al. (10) documented short-term improvements in 202 
microvascular function during the postprandial state after the intake of virgin olive oil. It is worth 203 
noting that differences in endothelial function between genders have been reported (27). Even though 204 
a greater FMD in females may be accounted for by their smaller vessel size (28), in premenopausal 205 
women, HDL and estrogen have been related to endothelial nitric oxide synthase (eNOS) stimulation 206 
(29). In our study, despite a predominance of women, the results do not seem to be influenced by 207 
gender distribution, as both the percent of females and the mean age of the women were similar in 208 
the two groups. Thus, our biochemical (PAI-1) and hemodynamic (IRHi) findings jointly provide 209 
evidence of a role for ICH on vascular dysfunction in small vessels.  210 
When both endothelial measurements (PAI-1 and IRHi) are shown separately according to the type 211 
of ICH, apparently different responses were observed. Improvements in PAI-1 were consistent with 212 
a slightly higher content of phenols and MUFA in acorn-fed ICH. Meanwhile, unexpectedly, only 213 
participants who consumed acorn-fed ICH seemed to improve IRHi, even though the study was not 214 
designed to find differences between both types of ICH. A comprehensive appraisal would be 215 
required to clarify this point, considering that vasodilation of the microvasculature involves not only 216 
nitric oxide, but also other vasodilatory factors such as prostaglandins (30).  217 
The assessment of the effect of ICH on oxidative stress (OE) was also among our secondary 218 
objectives. Neither TBARS nor F2-isoprostane/creatinine ratio showed significant differences 219 
between groups after 6 weeks. Although there is much evidence supporting that OE contributes to 220 
atherogenesis (31), the association between consumption of antioxidant-rich foods and reduction in 221 
OE markers is less overt. Previously, a small study (15) conducted in older adults showed that 222 
including ICH in the diet reduced lipid peroxidation. However, our results are consistent with several 223 
other well-conducted studies that failed to demonstrate dietary effects on OE (32, 33). Self-regulatory 224 
mechanisms as cellular and circulating enzymes and antioxidants could be involved in this 225 
relationship (34), making specifically designed studies necessary. In addition, our study took place 226 
in a Mediterranean country where, on average, diet is high in fruits and vegetables, what could 227 
contribute to explain the discrepancies between findings regarding endothelial function and OE. 228 
However, consumption of antioxidant-rich foods has shown to decrease OE in individuals with low 229 
dietary fruit and vegetable intake (35).  230 
Although endothelial function is a determinant factor of large artery hemodynamics (36), in our study 231 
neither central blood pressure nor augmentation index significantly differed between groups. Arterial 232 
stiffness depends not only on endothelium, but also, even more importantly, on structural elements 233 
within the arterial wall as well as on vessel pressure. Thus, in our study, changes in constituents such 234 
as collagen and elastin might be limited due to a short period of intervention. Moreover, ICH is high 235 
in salt, estimated at 1200mg/100g (13), which could adversely impact on blood pressure. However, 236 
as blood pressure changes did not differ between both groups, the possibly expected hypertensive 237 
response might have been offset by a favorable action at vascular level (37).  238 
Given ICH’s fatty acid composition and energy profile (13), there is a common concern about whether 239 
ICH consumption leads to undesired weight gain. In our study, participants’ anthropometric measures 240 
did not change significantly from baseline, considering that the inclusion of ICH in the diet – 241 
50g/daily representing less than 200 kcal- was framed within the total caloric content. Moreover, 242 
Ruiz-Canela et al. (16), after 6 years of follow-up among a 13,293 initially healthy subjects, reported 243 
no evidence of any association between the consumption of dry-cured ham and weight gain. 244 
Moreover, in our study metabolic parameters including lipid profile also remain unaffected. A 245 
previous study (14) reported a favorable impact of ICH on LDL and HDL cholesterol. However, in 246 
that case an additional source of the oleic acid – olive oil- was included, which could explain these 247 
apparently discordant findings. It is also noteworthy that triglycerides and uric acid remained 248 
unaltered.  249 
Furthermore, we observed that the improvement in endothelial function persisted for at least 6 weeks 250 
after completion of ICH consumption. Likewise it has been previously described that an “endothelial 251 
memory” exists following vascular stress (38, 39), our findings may suggest that this memory could 252 
conversely act as a sustained benefit after stopping the intervention. This fact would be in line with 253 
the metabolic legacy described, in the longer term, for statin therapy (40) and antidiabetic treatment 254 
(41). In this regard, it has been hypothesized that bioactive food components can influence epigenetic 255 
phenomena, either by inhibiting or modifying enzymatic reactions involved in DNA methylation or 256 
histone alterations (42).  257 
Overall, the improvement in endothelial function, as observed after regular ICH consumption, may 258 
have exciting implications in slowing down the process of aging beyond the prevention of the 259 
atherothrombotic disease, according to the modern vascular theory of aging (43). Current evidence 260 
(44) supports vascular oxidative stress and inflammation as the major mechanisms by which aging 261 
leads to age-associated endothelial dysfunction, even in the absence of clinical cardiovascular disease 262 
or its major risk factors (45). A number of interrelated processes underlie these mechanisms, such as 263 
increased bioactivity of endothelial vasoconstrictor and hypofibrinolytic molecules, activation of 264 
nuclear factor kappa B (NF-κB) signaling pathway and formation of advanced glycation end-products 265 
(AGEs) (46-50).  266 
We acknowledge several potential limitations to be considered in our study. First, given the nature of 267 
the tested food, the use of an active or placebo comparator was not possible. Similarly, the compliance 268 
assessment was limited. Even though a prescribed standardized diet could have allowed us to control 269 
for dietary variables, we decided to interfere as little as possible in their life-style patterns throughout 270 
the study in order to strengthen the real-life applicability of our findings. Second, the results regarding 271 
the two types of ICH should be carefully examined, as the study was not designed to assess 272 
differences between both types, but rather to provide additional insights on the role of different 273 
sources and compositions. Finally, the study was performed solely in Spanish healthy subjects, 274 
mostly women, so it is uncertain whether our findings could be extrapolated to different populations. 275 
The longer-term effects of ICH on endothelial function in patients with cardiovascular disease also 276 
remain to be examined in future studies.  277 
Conclusions  278 
The present study demonstrates for the first time that regular consumption of Iberian cured-ham 279 
(ICH) improves endothelial function in healthy adults. These improvements in PAI-1 levels and 280 
microvascular response to hyperemia were independent of classical cardiovascular risk factors, and 281 
seemed to remain for a 6-week period after stopping ICH consumption. Moreover, our study also 282 
indicates that ICH may be included in the diet without weight gain or increasing triglyceride levels 283 
at least in the short term.  284 
Given the increasing numbers of older adults and associated health care burden, effective strategies 285 
are needed to preserve or improve the endothelial function. In this regard, our results would seem 286 
particularly compelling, even though further and longer-term studies are needed to clarify the 287 
mechanisms involved in the relationship between nutrients, epigenetics, ageing and endothelium.  288 
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